Treating Spreading Small Cell Lung Cancer

Swedish and Norwegian scientists have presented a study on treating spreading small cell lung cancer at the American Society of Clinical Oncology in Chicago.

A new combination of cytotoxins increased life expectancy. There was a 34 percent survival rate after one year for patients participating in the study, compared to a 24 percent survival rate for those who received standard treatment.

Without any treatment, spreading small cell lung cancer is terminal within a few weeks. Each year some 3000 Swedes get lung cancer, of which 10 percent develop small cell cancer which spreads in the form of tumors in other organs.

The study backs up Japanese research from 2002 and Sverre Sörenson from Linköping’s University Hospital would like to see the new method become the new standard. American research presented last year did not find the new combination to decrease mortality.